SCHEMBL3153576

SCHEMBL3153576

CCCc1ccc(CCc2ccc3c(F)c(-c4ccc(OC(F)(F)F)cc4)ccc3c2)cc1

nearest known ligand 0.37

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
DAO P14920 1/20 0.37
FFAR4 Q5NUL3 2/20 0.36
FFAR1 O14842 1/20 0.36
GRM2 Q14416 1/20 0.36
MPL P40238 3/20 0.36
GPR84 Q9NQS5 1/20 0.36
CHRNA7 P36544 1/20 0.35
TSHR P16473 1/20 0.34
GSK3B P49841 1/20 0.34
CYP3A4 P08684 1/20 0.34
SLC6A4 P31645 3/20 0.34
SLC6A3 Q01959 3/20 0.34
NCEH1 Q6PIU2 2/20 0.34
ALOX5 P09917 1/20 0.33
PPARG P37231 1/20 0.33
PTGDR2 Q9Y5Y4 1/20 0.33
CYP11B1 P15538 1/20 0.33
CYP11B2 P19099 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3162399 0.98 GRM2 (0.37) FFAR4FFAR1GRM2MPLCHRNA7
SCHEMBL3170923 0.96 GSK3B (0.37) FFAR4FFAR1GRM2MPLCHRNA7
SCHEMBL3169965 0.94 DAO (0.38) DAOFFAR4FFAR1GRM2MPL
SCHEMBL3168473 0.93 MPL (0.41) DAOFFAR4FFAR1GRM2MPL
SCHEMBL6059636 0.93 GSK3B (0.39) DAOFFAR4FFAR1GRM2MPL
SCHEMBL5684909 0.93 GRM2 (0.36) FFAR4FFAR1GRM2MPLCHRNA7
SCHEMBL3165465 0.92 RARB (0.40) DAOMPLALOX5PPARG
SCHEMBL3160311 0.92 ALOX5AP (0.41) FFAR4FFAR1GRM2MPLCHRNA7
SCHEMBL3168243 0.91 RARB (0.42) MPLCYP3A4ALOX5PPARG
SCHEMBL3153017 0.91 RARB (0.42) MPLCYP3A4ALOX5PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1452514-B1 Naphthalene derivative and liquid crystal composition comprising the same DAINIPPON INK & CHEMICALS (JP) 2010-03-31 EP disclosed
EP-1273562-B1 Naphthalene derivative and liquid crystal composition comprising the same DAINIPPON INK & CHEMICALS (JP) 2009-07-22 EP disclosed
US-7145047-B2 Naphthalene derivative and liquid crystal composition comprising the same DAINIPPON INK AND CHEMICALS, INC. (JP) 2006-12-05 US disclosed
EP-0952135-B1 Naphthalene derivative and liquid crystal composition comprising the same DAINIPPON INK & CHEMICALS (JP) 2005-01-05 EP disclosed
EP-1452514-A1 Naphthalene derivative and liquid crystal composition comprising the same DAINIPPON INK AND CHEMICALS, INC. (JP) 2004-09-01 EP disclosed
US-20030136944-A1 Naphthalene derivative and liquid crystal composition comprising the same DAINIPPON INK AND CHEMICALS, INC. (JP) 2003-07-24 US disclosed
EP-1273562-A1 Naphthalene derivative and liquid crystal composition comprising the same DAINIPPON INK AND CHEMICALS, INC. (JP) 2003-01-08 EP disclosed
US-6468607-B1 MISCIBILITY, LARGE BIREFRINGENCE INDEX, NO STRONGLY POLAR GROUP IN ITS MOLECULE AND THUS CAN ALSO BE USED FOR ACTIVE MATRIX DRIVING, WIDE TEMPERATURE RANGE AND REQUIRES A HIGH SPEED RESPONSE AND A LOW VOLTAGE DRIVING DAINIPPON INK AND CHEMICALS, INC. (JP) 2002-10-22 US disclosed
EP-0952135-A1 Naphthalene derivative and liquid crystal composition comprising the same DAINIPPON INK AND CHEMICALS, INC. (JP) 1999-10-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030136944-A1 Naphthalene derivative and liquid crystal composition comprising the same NLK, NOTCH1, NOTCH4 DAO 3841/4885FFAR4 3795/4885FFAR1 4057/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.